Malignant Ethmoid Sinus Tumor Masquerading as Chronic Ethmoid Sinusitis

Moreover, a variety of cisplatin-based chemotherapeutic protocols can be added to the treatment regimen for patients with known or suspected regional or distant metastatic disease. For example, Uchida et al reported a 5-year survival rate of only 25% among 20 patients with ethmoid SCC who were treat...

Full description

Saved in:
Bibliographic Details
Published in:Ear, nose, & throat journal nose, & throat journal, 2006-12, Vol.85 (12), p.814-816
Main Authors: Wright, Byron E., Hamilton, Jason S., Osborne, Ryan F.
Format: Article
Language:English
Subjects:
Aged
Breast cancer
Carcinoma, Squamous Cell - diagnostic imaging
Case studies
Diagnosis
Diagnosis, Differential
Ethmoid Sinus - diagnostic imaging
Ethmoid Sinusitis - diagnostic imaging
Female
Head & neck cancer
Humans
Paranasal sinus diseases
Paranasal Sinus Neoplasms - diagnostic imaging
Patients
Radiation therapy
Radiography
Sinuses
Skin cancer
Squamous cell carcinoma
Tumors
Citations: Items that this one cites
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Moreover, a variety of cisplatin-based chemotherapeutic protocols can be added to the treatment regimen for patients with known or suspected regional or distant metastatic disease. For example, Uchida et al reported a 5-year survival rate of only 25% among 20 patients with ethmoid SCC who were treated with either radiotherapy plus surgery or radiotherapy alone.1 Dulguerov et al reported a 5-year survival rate of 48% among 220 patients with ethmoid carcinoma, but they did not distinguish among multiple histologic subtypes.3 They also suggested that survival was better among patients who underwent surgery or surgery plus radiation rather than radiation alone.
ISSN:0145-5613
1942-7522
DOI:10.1177/014556130608501209